[Pregnant woman with severe asthenia due to vitamin cocktail].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to C Ibáñez Ruiz.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
OBJECTIVES: To discover the view of primary care doctors on aspects of the safety of medicines, their knowledge of the programme of automatic notification of negative side-effects of medicines (NSEM), their opinion of the programme and factors affecting low notification. DESIGN: A survey of views. SETTING: Madrid's Health Area 1. PARTICIPANTS: General practitioners and paediatricians (n = 417). MEASUREMENTS AND RESULTS: 281 doctors (67.4%) replied. 88.4% (48 + 40.4%) said they included questions on possible side-effects in the case history interview (always or almost always). 58.2% suspected at least one negative side-effect each month. CONCLUSIONS: Doctors are very interested in detecting and identifying the NSEM of their patients, and therefore believe that a centralised system to record NSEM should be set up.
OBJECTIVES: To determine the prevalence in out-patients of risk factors leading to venous thromboembolic disease (VTE); and to analyse what perception primary care centre (PCC) doctors have of this risk and what attitude they adopt to therapy. DESIGN: 1) An observational, crossover study, with patients included at random. 2) A study with a teaching intervention, which was neither controlled nor randomised. PATIENTS: PCC patients over 25 seen either on demand, with appointments or at home. INTERVENTION: A clinical history was composed, using a closed questionnaire. A risk category and therapeutic attitude were then assigned. A guide on prevention and treatment of VTD was presented and discussed in clinical sessions. RESULTS: 11 PCC doctors polled 272 patients. 45 of these had moderate to high risk of VTD; and 4 had one of the criteria of the European Accord on VTD prevention for commencing prophylactic treatment. In two of these four, it was thought necessary to start prophylaxis. CONCLUSIONS: The prevalence of patients with moderate to high risk of VTD is 17% in patients over 25 who seek medical attention at PCCs. Doctors detected 50% of moderate to high risk patients. If the criteria used for in-patients were followed, prophylaxis should have been started in 1.5% of patients.